Freestone Grove Partners LP Roivant Sciences Ltd. Transaction History
Freestone Grove Partners LP
- $13.2 Trillion
- Q2 2025
A detailed history of Freestone Grove Partners LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Freestone Grove Partners LP holds 31,515 shares of ROIV stock, worth $539,221. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,515Holding current value
$539,221% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
364Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$1.03 Billion5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$765 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$673 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$605 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$586 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $12.1B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...